A medication trusted by clinicians for decades to fight life-threatening infections is now under scrutiny: new research suggests cefepime, one of the most commonly prescribed broad-spectrum antibiotics in hospitals worldwide, may be associated with higher mortality than comparable alternatives in its drug class. The finding does not overturn established practice overnight, but it introduces a quiet uncertainty into a routine decision made thousands of times each day — the choice of which antibiotic to reach for first. Medicine has always advanced by questioning what it thought it knew, and thi
Study Links Common Antibiotic Cefepime to Higher Mortality Risk
Potential increased mortality risk for patients treated with cefepime compared to alternative antibiotics.